Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), is a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections. It announced today ...

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators reveals how melanoma, the deadliest form of skin cancer, evolves to resist immunotherapy and identifies a potential ...

One hundred years after the heroic journey to Nome, scientists reveal how Balto's DNA explains his incredible endurance and ...

Could yeast and humans be any more different? Going by looks alone, probably not. But peering into our genomes reveals ...

The screenwriting duo behind The Woman in Cabin 10 break down reshaping the story for film, from redefining Lo as a ...

A simple penciclovir cream may help cats with recurring eye infections. It keeps antiviral levels steady for hours, reducing ...

A novel tool could reduce the time it takes to diagnose and classify acute leukemias from days to hours through DNA ...

Research shows superagers don’t share a similar diet or lifestyle, but they share one vital trait. You can copy it.

The key to these vaccines was messenger RNA (mRNA ... class of molecules works in the body and how it might be leveraged to ...

D-Mart continues to define India’s value-retail success story, with FY25 revenue topping Rs 55,000 crore and steady 8 % ...

Google’s Quantum Echoes now closes the loop: verification has become a measurable force, a resonance between consciousness and method. The many worlds seem to be bleeding together. Each observation is ...

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that KYGEVVI® has been granted approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults and ...